Discover how WuXi AppTec's In Vitro ADME team leverages 15+ years of expertise, 200+ experimental models, and advanced technology to transform drug discovery. From permeability and metabolic stability to regulatory-compliant IND support, we strive to turn the 0.1% possibility into a reality.
Related Resources
-
Dig Deeper | 20 Years of WuXi AppTec DMPK
VideosOct 17, 2026Learn More -
ADME-PK Solutions for Peptides and Oligos
WebinarsOct 16, 2026Learn More -
Evaluating the In Vitro Stability of Antibody-Drug Conjugates in Blood Matrixes
ArticlesSep 17, 2026Learn More -
Comparative Evaluation of Ultrafiltration and EMSA Formats for siRNA Plasma Protein Binding: Methodological Determinants and Artifacts
PublicationsJul 02, 2026Learn More -
Rapid Determination of Plasma Protein Binding and Dissociation Kinetics Using Dextran-Coated Charcoal Method Assessment and Optimization for Unstable and Highly Bound Compounds
PostersJun 09, 2026Learn More -
Methodological Comparison of Microsomal Protein Binding: Equilibrium Dialysis, Pre‑Saturation, and Flux Dialysis for Highly Bound Compounds
PostersJun 05, 2026Learn More -
DMPK Strategies for Proteolysis-Targeting Chimeras: Addressing ADME and PK Challenges
WebinarsJun 05, 2026Learn More -
The Impact of Probe Substrate Selection on Reducing Off-Target Effects in Enzyme Phenotyping of Slow-metabolizing Drugs
PostersJun 01, 2026Learn More -
Application of Acoustic Ejection Mass Spectrometry for Plasma Protein Binding Assay Using Flux Dialysis
PublicationsApr 29, 2026Learn More -
HSA Biomimetic Chromatography: Rapid Determination of Fraction Unbound (fu) in PPB Studies for Challenging Compounds
ArticlesMar 19, 2026Learn More
Stay Connected
Keep up with the latest news and insights.
Thanks for signing up
Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.
-
Not Now
-
Customize Now
Thanks for signing up
Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.
-
Not Now
-
Customize Now